首页> 美国卫生研究院文献>World Journal of Gastroenterology >Individualized peri-operative fluid therapy facilitating early-phase recovery after liver transplantation
【2h】

Individualized peri-operative fluid therapy facilitating early-phase recovery after liver transplantation

机译:个性化的围手术期液体疗法有助于肝移植后的早期恢复

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate the correlation between peri-operative fluid therapy and early-phase recovery after liver transplantation (LT) by retrospectively reviewing 102 consecutive recipients.METHODS: Based on whether or not the patients had pulmonary complications, the patients were categorized into non-pulmonary and pulmonary groups. Twenty-eight peri-operative variables were analyzed in both groups to screen for the factors related to the occurrence of early pulmonary complications.RESULTS: The starting hemoglobin (Hb) value, an intra-operative transfusion > 100 mL/kg, and a fluid balance ≤ -14 mL/kg on the first day and the second or third day post-operatively were significant factors for early pulmonary complications. The extubation time, time to initial passage of flatus, or intensive care unit length of stay were significantly prolonged in patients who had not received an intra-operative transfusion ≤ 100 mL/kg or a fluid balance ≤ -14 mL/kg on the first day and the second or the third day post-operatively. Moreover, these patients had poorer results in arterial blood gas analysis.CONCLUSION: It is important to offer a precise and individualized fluid therapy during the peri-operative period to the patients undergoing LT for cirrhosis-associated hepatocellular carcinoma.
机译:目的:回顾性审查102名连续接受者,以探讨围手术期液体疗法与肝移植术后早期恢复之间的相关性。方法:根据患者是否患有肺部并发症,将患者分为非肺和肺组。两组均分析了28个围手术期变量,以筛选与早期肺部并发症发生有关的因素。结果:起始血红蛋白(Hb)值,术中输血> 100 mL / kg和输液术后第一天,第二天或第三天平衡≤-14 mL / kg是早期肺部并发症的重要因素。首次拔管时未接受术中输注≤100 mL / kg或体液平衡≤-14 mL / kg的患者,拔管时间,开始出现肠胃气的时间或重症监护病房的住院时间明显延长术后第二天和第二天或第三天。此外,这些患者的动脉血气分析结果较差。结论:在围手术期为接受肝硬化相关性肝细胞癌的LT患者提供精确和个性化的液体治疗非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号